TBVAC Horizon – A boost for research towards a better understanding of local lung immunity to tuberculosis infection

VFI is pleased to pursue its collaboration with TBVAC in the pursuit of a safe and effective vaccine against tuberculosis. VFI will provide adjuvants and formulation expertise to accelerate the development of TBVAC’s promising vaccine candidates, and to advance towards a world without tuberculosis. The VFI team is proud to be part of this crucial effort and look forward to the positive impact our work will have on public health.

For News release read here

Share on linkedin
Share on reddit
Share on facebook
Share on twitter
Share on email